Dataset Information

De novo mutations in PLXND1 and REV3L cause Mobius syndrome.

ABSTRACT: Möbius syndrome (MBS) is a neurological disorder that is characterized by paralysis of the facial nerves and variable other congenital anomalies. The aetiology of this syndrome has been enigmatic since the initial descriptions by von Graefe in 1880 and by Möbius in 1888, and it has been debated for decades whether MBS has a genetic or a non-genetic aetiology. Here, we report de novo mutations affecting two genes, PLXND1 and REV3L in MBS patients. PLXND1 and REV3L represent totally unrelated pathways involved in hindbrain development: neural migration and DNA translesion synthesis, essential for the replication of endogenously damaged DNA, respectively. Interestingly, analysis of Plxnd1 and Rev3l mutant mice shows that disruption of these separate pathways converge at the facial branchiomotor nucleus, affecting either motoneuron migration or proliferation. The finding that PLXND1 and REV3L mutations are responsible for a proportion of MBS patients suggests that de novo mutations in other genes might account for other MBS patients.

SUBMITTER: Tomas-Roca L

PROVIDER: S-EPMC4648025 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

De novo mutations in PLXND1 and REV3L cause Möbius syndrome.

Tomas-Roca Laura L Tsaalbi-Shtylik Anastasia A Jansen Jacob G JG Singh Manvendra K MK Epstein Jonathan A JA Altunoglu Umut U Verzijl Harriette H Soria Laura L van Beusekom Ellen E Roscioli Tony T Iqbal Zafar Z Gilissen Christian C Hoischen Alexander A de Brouwer Arjan P M APM Erasmus Corrie C Schubert Dirk D Brunner Han H Pérez Aytés Antonio A Marin Faustino F Marin Faustino F Aroca Pilar P Kayserili Hülya H Carta Arturo A de Wind Niels N Padberg George W GW van Bokhoven Hans H

Nature communications 20150612

Möbius syndrome (MBS) is a neurological disorder that is characterized by paralysis of the facial nerves and variable other congenital anomalies. The aetiology of this syndrome has been enigmatic since the initial descriptions by von Graefe in 1880 and by Möbius in 1888, and it has been debated for decades whether MBS has a genetic or a non-genetic aetiology. Here, we report de novo mutations affecting two genes, PLXND1 and REV3L in MBS patients. PLXND1 and REV3L represent totally unrelated path ...[more]

PMID: 26068067

Dataset Information

De novo mutations in PLXND1 and REV3L cause Mobius syndrome.

Publications

De novo mutations in PLXND1 and REV3L cause Möbius syndrome.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Similar Datasets

De Novo Mutations in EBF3 Cause a Neurodevelopmental Syndrome.
| S-EPMC5223060 | biostudies-literature

De novo mutations in MLL cause Wiedemann-Steiner syndrome.
| S-EPMC3415539 | biostudies-literature

Dominant de novo DSP mutations cause erythrokeratodermia-cardiomyopathy syndrome.
| S-EPMC4706118 | biostudies-literature

Recessive and Dominant De Novo ITPR1 Mutations Cause Gillespie Syndrome.
| S-EPMC4863566 | biostudies-literature

HOXA1 mutations are not a common cause of Mobius syndrome.
| S-EPMC2862693 | biostudies-literature

TUBB4A de novo mutations cause isolated hypomyelination.
| S-EPMC4153852 | biostudies-literature

Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome.
| S-EPMC10540076 | biostudies-literature

De Novo GMNN Mutations Cause Autosomal-Dominant Primordial Dwarfism Associated with Meier-Gorlin Syndrome.
| S-EPMC4678788 | biostudies-literature

De novo mutations of the gene encoding the histone acetyltransferase KAT6B cause Genitopatellar syndrome.
| S-EPMC3276665 | biostudies-literature

De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome.
| S-EPMC3677859 | biostudies-literature